InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
100%
T+90 mean return
+32.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by EVNIN LUKE, Director. Director active across 1 company, notably Werewolf Therapeutics, Inc.. Cumulatively, 11 disclosures have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €73k. Activity tracked since 27 March 2025. The latest transaction was filed on 5 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
157,084 sharesCommon StockSEC:0001134657-26-000019:0
76,928 sharesCommon StockSEC:0001134657-26-000018:0
20,072 shares@ US$0.440.042% mcap10.1% of flowCommon StockSEC:0001134657-26-000017:0
24,946 shares@ US$0.400.047% mcap11.4% of flowCommon StockSEC:0001134657-26-000017:1
60,547 sharesCommon StockSEC:0001134657-26-000017:2
80,852 shares@ US$0.480.15% mcap56.2% of flowCommon StockSEC:0001134657-26-000015:0
27,698 shares@ US$0.460.050% mcap18.5% of flowCommon StockSEC:0001134657-26-000015:1
32,556 shares@ US$0.450.058% mcap21.3% of flowCommon StockSEC:0001134657-26-000015:2
28,113 shares@ US$0.094.0% of flowCommon StockSEC:0001415889-25-011570:0
2,756,073 sharesCommon StockSEC:0001209191-21-030623
2,756,073 sharesCommon StockSEC:0001209191-21-030623:0
11 of 11 declarations
About EVNIN LUKE
Luke Evnin is a Director at Werewolf Therapeutics, Inc. He brings expertise in governance and corporate strategy. Evnin is involved in overseeing the operations and strategic initiatives of the company, aimed at developing innovative treatments in biotechnology. His commitment to innovation and scientific excellence is an asset to Werewolf Therapeutics.
